Crohn's Disease and Colitis Trial, Recruiting NCT06505304 Sponsor: University College Cork Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06505304
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 75 years of age
  • People who have been diagnosed with Crohn's disease (CD) for at least six months before the start of the study
  • People who have had bowel surgery within the 3 months before joining the study, or who have bowel surgery planned

Who may not be able to join:

  • People who are unable to give their own consent to participate
  • People with serious other health conditions that a doctor considers a medical reason not to participate
  • People who have a stoma (an opening on the abdomen connected to the bowel)
  • People who are pregnant or breastfeeding
  • People for whom a colonoscopy (camera examination of the bowel) or taking small tissue samples would not be safe
  • People whose bowel was not well enough cleaned before the procedure, based on a specific preparation score (confirm with trial site)
  • People who have an allergy to nuts or shellfish — this applies only to the pCLE part of the study (a special imaging technique used during the procedure)
  • People with severe or poorly controlled asthma — this applies only to the pCLE part of the study
  • People currently taking beta-blocker medications — this applies only to the pCLE part of the study
  • People who have previously had a reaction to a dye called fluorescein — this applies only to the pCLE part of the study

Note: People who do not meet the requirements for the pCLE part of the study may still be able to take part in the standard endoscopy part of the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marietta Iacucci, Professor, APC Microbiome Ireland, University College Cork

Phone: +353 (0)21 4901759

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University College Cork
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
31 October 2025

Where this trial is recruiting

🇧🇪 Belgium 🇨🇦 Canada 🇩🇪 Germany 🇮🇪 Ireland 🇮🇱 Israel 🇮🇹 Italy

Primary endpoints

Early post-operative endoscopic recurrence; Early post-operative clinical recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov